N‐terminal pro–brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium‐channel blockers

2003127 citationsJournal Article

Authors

Yannick Allanore · Assistance Publique – Hôpitaux de Paris

Didier Borderie · Assistance Publique – Hôpitaux de Paris

Christophe Meune · Assistance Publique – Hôpitaux de Paris

Laure Cabanes · Hôpital Cochin

Simon Weber · Assistance Publique – Hôpitaux de Paris

Ohvanesse G. Ekindjian · Hôpital Cochin

André Kahan

Abstract

NT-proBNP is a useful biologic marker that can be used to diagnose early PAH in SSc patients without clinical heart failure. Measurement of NT-proBNP may be valuable for the evaluation of treatment with DTCCB and vasodilators in patients with PAH.

Topics & Keywords

Pulmonary Hypertension Research and Treatments Systemic Sclerosis and Related Diseases Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Arthritis & Rheumatism

Volume 48, Issue 12, pp. 3503-3508

DOI: 10.1002/art.11345

Field-Weighted Citation Impact: 4.64